These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22560791)

  • 21. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited.
    Biederman J; Faraone SV; Monuteaux MC; Bober M; Cadogen E
    Biol Psychiatry; 2004 Apr; 55(7):692-700. PubMed ID: 15038997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurobehavioral characteristics of children with Duchenne muscular dystrophy.
    Donders J; Taneja C
    Child Neuropsychol; 2009 May; 15(3):295-304. PubMed ID: 19160150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duchenne muscular dystrophy: a clinical, histopathological and genetic study at a neurology tertiary care center in Southern India.
    Swaminathan B; Shubha GN; Shubha D; Murthy AR; Kiran Kumar HB; Shylashree S; Gayathri N; Jamuna R; Jain S; Purushottam M; Nalini A
    Neurol India; 2009; 57(6):734-8. PubMed ID: 20139501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study on cognitive impairment in Duchenne muscular dystrophy.
    Zhang XF; Luo YY; Jiang L; Hong SQ
    Neuromuscul Disord; 2023 Jul; 33(7):596-604. PubMed ID: 37385106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinic attenders with autism or attention-deficit/hyperactivity disorder: cognitive profile at school age and its relationship to preschool indicators of language delay.
    Hagberg BS; Miniscalco C; Gillberg C
    Res Dev Disabil; 2010; 31(1):1-8. PubMed ID: 19713073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
    Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
    Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Third case of Duchenne muscular dystrophy and West syndrome: Expanding the spectrum of the DMD neuropsychiatric phenotype.
    Peña-Padilla C; Romero-Valenzuela I; Baldomero-López A; Sandoval-Talamantes AK; Castellanos-González A; Nagy PL; Kelly RR; Corona-Rivera JR
    Neuromuscul Disord; 2021 May; 31(5):462-465. PubMed ID: 33741226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
    Eisenberg J; Mei-Tal G; Steinberg A; Tartakovsky E; Zohar A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Oct; 88(5):497-502. PubMed ID: 10490706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder.
    Smalley SL; McGough JJ; Del'Homme M; NewDelman J; Gordon E; Kim T; Liu A; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1135-43. PubMed ID: 10986810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations.
    Ricotti V; Mandy WP; Scoto M; Pane M; Deconinck N; Messina S; Mercuri E; Skuse DH; Muntoni F
    Dev Med Child Neurol; 2016 Jan; 58(1):77-84. PubMed ID: 26365034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
    Johann M; Bobbe G; Putzhammer A; Wodarz N
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta-analysis.
    Pascual-Morena C; Cavero-Redondo I; Álvarez-Bueno C; Jiménez-López E; Saz-Lara A; Martínez-García I; Martínez-Vizcaíno V
    Dev Med Child Neurol; 2023 Jun; 65(6):734-744. PubMed ID: 36440509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy and comorbid attention-deficit hyperactivity disorder using propensity-score matching.
    Xu RH; Dai Y; Ng SSM; Zhang S; Dong D
    J Affect Disord; 2023 Jul; 333():147-153. PubMed ID: 37084967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform.
    Lim BC; Lee S; Shin JY; Kim JI; Hwang H; Kim KJ; Hwang YS; Seo JS; Chae JH
    J Med Genet; 2011 Nov; 48(11):731-6. PubMed ID: 21969337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early histories of school-aged children with attention-deficit/hyperactivity disorder.
    Loe IM; Balestrino MD; Phelps RA; Kurs-Lasky M; Chaves-Gnecco D; Paradise JL; Feldman HM
    Child Dev; 2008; 79(6):1853-68. PubMed ID: 19037954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.
    Taylor PJ; Betts GA; Maroulis S; Gilissen C; Pedersen RL; Mowat DR; Johnston HM; Buckley MF
    PLoS One; 2010 Jan; 5(1):e8803. PubMed ID: 20098710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical presentation of attention deficit/hyperactivity disorder as a function of the gender].
    Montiel-Nava C; Montiel-Barbero I; Peña JA
    Invest Clin; 2007 Dec; 48(4):459-68. PubMed ID: 18271391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.
    Masi G; Perugi G; Toni C; Millepiedi S; Mucci M; Bertini N; Pfanner C
    Bipolar Disord; 2006 Aug; 8(4):373-81. PubMed ID: 16879138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.